{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:27:27Z","timestamp":1791178047038,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":355,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG040092"],"award-info":[{"award-number":["AG040092"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG020159"],"award-info":[{"award-number":["R01 AG020159"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ajpath.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T02:48:00Z","timestamp":1370573280000},"page":"369-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Pyroglutamate-3 Amyloid-\u03b2 Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease\u2013Like Transgenic Mouse Models"],"prefix":"10.1016","volume":"183","author":[{"given":"Jeffrey L.","family":"Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin X.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Cynis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ekpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta M.","family":"Palmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R.","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Snigdha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl W.","family":"Cotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi C.","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter St.","family":"George-Hyslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneya","family":"Ikezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Lemere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.05.005_bib1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2013.05.005_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.05.005_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2013.05.005_bib4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.1064638","article-title":"A portrait of Alzheimer secretases\u2014new features and familiar faces","volume":"293","author":"Esler","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.05.005_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2011.09.071","article-title":"Pyroglutamate A\u03b2 3 and 11 colocalize in amyloid plaques in Alzheimer's disease cerebral cortex with pyroglutamate-A\u03b2 11 forming the central core","volume":"505","author":"Sullivan","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ajpath.2013.05.005_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2013.05.005_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2013.05.005_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","article-title":"Amino and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain","volume":"215","author":"Saido","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ajpath.2013.05.005_bib9","first-page":"1823","article-title":"Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques","volume":"149","author":"Iwatsubo","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib10","doi-asserted-by":"crossref","first-page":"34186","DOI":"10.1074\/jbc.M501694200","article-title":"beta-Amyloid is different in normal aging and in Alzheimer disease","volume":"280","author":"Piccini","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib11","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"Schlenzig","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.05.005_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-5793(04)00300-X","article-title":"Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions","volume":"563","author":"Schilling","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2013.05.005_bib14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1046\/j.1471-4159.2002.01107.x","article-title":"Pyroglutamate-modified amyloid beta-peptides\u2014AbetaN3(pE)\u2014strongly affect cultured neuron and astrocyte survival","volume":"82","author":"Russo","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib15","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi990563r","article-title":"The Abeta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in\u00a0vitro than full-length Abeta","volume":"38","author":"He","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib16","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/bi0612667","article-title":"On the seeding and oligomerization of pGlu-amyloid peptides (in\u00a0vitro)","volume":"45","author":"Schilling","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","article-title":"N-terminal pyroglutamate formation of A\u03b238 and A\u03b240 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation","volume":"121","author":"Schlenzig","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib18","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1021\/bi800250p","article-title":"Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta","volume":"47","author":"Cynis","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05471.x","article-title":"Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical\/hippocampal microinjection in\u00a0vivo\/in situ","volume":"106","author":"Schilling","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2013.05.005_bib21","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1523\/JNEUROSCI.1794-11.2011","article-title":"Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Abeta is induced by pyroglutamate-Abeta formation","volume":"31","author":"Alexandru","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2013.05.005_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00702-009-0314-x","article-title":"Pyroglutamate Abeta pathology in APP\/PS1KI mice, sporadic and familial Alzheimer's disease cases","volume":"117","author":"Wirths","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ajpath.2013.05.005_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-011-0806-2","article-title":"Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Abeta deposits in hippocampus via distinct cellular mechanisms","volume":"121","author":"Hartlage-Rubsamen","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-2011-111208","article-title":"Detection of peri-synaptic amyloid-beta pyroglutamate aggregates in early stages of Alzheimer's disease and in A\u03b2PP transgenic mice using a novel monoclonal antibody","volume":"28","author":"Mandler","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2013.05.005_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9440(10)63296-8","article-title":"Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet","volume":"165","author":"Lemere","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0197-4580(93)90038-D","article-title":"Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease","volume":"14","author":"Cummings","year":"1993","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2013.05.005_bib29","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of A\u00a71-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","article-title":"Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life","volume":"36","author":"Shankar","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2013.05.005_bib31","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.1247","article-title":"Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42)","volume":"66","author":"Rockenstein","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2013.05.005_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.05.005_bib34","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0002-9440(10)62364-4","article-title":"Overexpression of monocyte chemotactic protein-1\/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition","volume":"166","author":"Yamamoto","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib35","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.M312946200","article-title":"Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor","volume":"279","author":"Davis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib36","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2013.05.005_bib38","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2013.05.005_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2013.05.005_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","article-title":"Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain","volume":"276","author":"Harigaya","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2013.05.005_bib42","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1021\/bi0508237","article-title":"Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques","volume":"44","author":"Miravalle","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/nbdi.2000.0357","article-title":"Amino-terminal modification and tyrosine phosphorylation of carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain","volume":"8","author":"Russo","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2013.05.005_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","article-title":"High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain","volume":"143","author":"Guntert","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajpath.2013.05.005_bib45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archneur.64.5.738","article-title":"Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype","volume":"64","author":"Piccini","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2013.05.005_bib46","doi-asserted-by":"crossref","first-page":"11831","DOI":"10.1021\/bi9018835","article-title":"Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates","volume":"48","author":"Seifert","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijdevneu.2009.08.007","article-title":"Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain","volume":"27","author":"Hartlage-Rubsamen","year":"2009","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib48","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1074\/jbc.M110.185819","article-title":"Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A\u03b2 formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice","volume":"286","author":"Jawhar","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.05.005_bib50","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/bi015685+","article-title":"APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques","volume":"41","author":"Kalback","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2013.05.005_bib51","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1074\/jbc.M209065200","article-title":"Presenilin-1 regulates intracellular trafficking and cell surface delivery of \u03b2-amyloid precursor protein","volume":"278","author":"Cai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-4159.2007.04587.x","article-title":"Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in\u00a0vivo","volume":"102","author":"Gandy","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2013.05.005_bib53","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A\u03b242 deposition and severe cerebellar pathology","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:42:34Z","timestamp":1757601754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0002944013003532"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.005","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyroglutamate-3 Amyloid-\u03b2 Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease\u2013Like Transgenic Mouse Models","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}